Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $7.3000 (3.84%) ($6.6400 - $7.3000) on Wed. May. 4, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.68% (three month average) | RSI | 34 | Latest Price | $7.3000(3.84%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 1.9% a day on average for past five trading days. | Weekly Trend | ATRA declines -6.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(47%) IBB(44%) ARKK(43%) ARKG(42%) XAR(41%) | Factors Impacting ATRA price | ATRA will decline at least -2.34% in a week (0% probabilities). VIXM(-39%) VXX(-26%) UNG(-17%) USO(-11%) TLT(-8%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.34% (StdDev 4.68%) | Hourly BBV | 2.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-13.3(-282.19%) | Resistance Level | $7.61 | 5 Day Moving Average | $6.86(6.41%) | 10 Day Moving Average | $6.96(4.89%) | 20 Day Moving Average | $7.61(-4.07%) | To recent high | -53.4% | To recent low | 14.8% | Market Cap | $542m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |